The role of nitric oxide in genetic model of absence epilepsy in rats
✍ Scribed by B. Przewlocki; W. Lasoń; G. van Luijtelaar; T. Coenen; R. Przewlocki
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 387 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0893-6609
No coin nor oath required. For personal study only.
✦ Synopsis
Involvement of nitric oxide (NO) in the regulation of the epileptic activity was studied in WAG/Rij rats, a genetic model of absence epilepsy. I.c.v. administration of NO donors: S-nitroso-Nacetylpenicillamine (SNAP, 0.5 and 5 pg), 3-morpholino-sydnonimine (SIN-1, 0.5 and 5 pg) or sodium nitroprusside (SNP, 2 and 20 pg) enhanced namber of spike wave discharges (SWD) after the higher dose and had no effect on the mean duration of SWD. On the other hand, i.c.v. administration of NO synthase inhibitors, L-p-Nitroarginine (NARG, 20, Zoopg) or L-NO-Nitro-arginine methyl ester (L-NAME, 20, 100 pg) dose-dependently decreased the number of SWD. None of the NO synthase inhibitors affected mean duration of SWD.
In contrast to i.c.v., the peripheral administration of L-NAME (7.5 -60 mg/kg i.p.) increased the number of SWD and had no effects on their duration. These results suggest that NO synthetized in the central nervous system promotes absence seizures in WAG/RIj rats, however peripheral administration of L-NAME aggravates absence epilepsy.
📜 SIMILAR VOLUMES
The association of nitric oxide (NO) with the hypotensive effects of adrenomedullin (AM) was investigated in anesthetized rats. Spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY) were used at 11-13 weeks of age. Blood pressure and heart rate were measured from the femoral
The relaxing effect of adrenomedullin (AM) and that associated with nitric oxide (NO) were investigated in rat isolated aorta. The relaxing effect produced by AM was almost completely inhibited by the removal of endothelium and by treatment with the NOS inhibitor fl-nitro-L-arginine methyester (L-NA
Nitric oxide (NO) is a gaseous neurotransmitter that may mediate a decrease in sympathetic output to the periphery. This implication predicts that NO-producing neurons in the brain are activated in animals experiencing increased levels of sympathetic activity. To test this prediction, we subjected t
An antiserum raised against the peptide representing the partial sequence 196-222 of mouse liver argininosuccinate synthetase (ASS) was used to detect and localize the enzyme in cells of neural primary cultures. No ASS immunoreactivity was detected by Western blotting in homogenates of mouse pure as